Sarah Romano

Track

Insider profile

Currently holds a position at EyeGate Pharmaceuticals Inc

Performance

Overall performance
4.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer EyeGate Pharmaceuticals Inc March 2, 2018 -
Interim Chief Financial Officer, Corporate Controller EyeGate Pharmaceuticals Inc Feb. 1, 2017 - Jan. 1, 2018
Sarah Romano's trades of GridAI Technologies Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-08 2025-01-06
S Sale
3,603 +13.6%
429.08
US$3,233,630 		3,603 +13.6% 429.08 US$3,233,630
2024-10-10 2024-10-09
S Sale
28,073 -11.4%
97.71
US$2,717,119 		28,073 -11.4% 97.71 US$2,717,119
2024-07-03 2024-07-02
S Sale
97,859 -11.6%
239.37
US$242,847 		97,859 -11.6% 239.37 US$242,847
2024-04-03 2024-04-01
S Sale
75 -0.4%
4.23
US$317 		75 -0.4% 4.23 US$317
2024-03-19 2024-03-15
S Sale
1,120 -5.5%
4.96
US$5,555 		1,120 -5.5% 4.96 US$5,555
2024-01-17 2024-01-12
S Sale
98 -0.5%
4.20
US$412 		98 -0.5% 4.20 US$412
2023-10-06 2023-10-04
S Sale
1,676 -9.6%
0.29
US$486 		1,676 -9.6% 0.29 US$486
2023-07-05 2023-07-03
S Sale
1,977 -10.2%
1.54
US$3,045 		1,977 -10.2% 1.54 US$3,045
2023-04-05 2023-04-03
S Sale
1,975 -9.2%
2.50
US$4,938 		1,975 -9.2% 2.50 US$4,938
2019-07-15 2019-07-15
S Sale
6,584 -2.5%
0.23
US$1,534 		6,584 -2.5% 0.23 US$1,534
2019-07-15 2019-07-12
S Sale
6,583 -2.4%
0.24
US$1,551 		6,583 -2.4% 0.24 US$1,551
2019-07-15 2019-07-11
S Sale
6,583 -2.3%
0.24
US$1,584 		6,583 -2.3% 0.24 US$1,584